drugset / Trial / NCT00542711
Bio-availability of a New Liquid Tumeric Extract
RandomizedCrossoverOpen-labelTreatment
Summary
Curcumin is a commonly-used spice and food coloring. Evidence suggests that curcumin can suppress tumor initiation, promotion and metastasis in a variety of tumor cell lines. The current available curcumin has low bioavailability restricting the effect of curcumin in non-colon cancer. In this study we plan to test a new liquid tumeric/curcumin extract, Curcumol (patent pending, Israel Patent Application No. 181,121). We predict the bioavailability of the liquid tumeric/curcumin extract will be better compared to the currently used curcumin powder.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Outcome
Outcome not reported
Stopped: “Technical difficulties”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Curcumol | Unknown | 30 unknown | — |
| Subject | Curcumol | Unknown | 50 unknown | — |
| Subject | Curcumol | Unknown | 70 unknown | — |
Indications
No indication recorded.